Document is current
Any future updates will be listed below
-
Authors
Ter Avest, Milou M
Nissen, Loes HC
Bosman, Sabien JE
Dijkman, Ilse
Speckens, Anne EM
Huijbers, Marloes J
- License Information
-
More Information
Article History
Received: 25 August 2025
Accepted: 14 July 2026
First Online: 14 August 2026
Change Date: 28 August 2026
Change Type: Update
Change Details: The author would like to remove the email address of the rest of the co-authors.
Declarations
Ethics Statement: The MindIBD trial, including this mixed-methods study, has been approved by the ethical review board CMO Arnhem-Nijmegen (#2021–7319; NL75762.091.20) and was conducted according to the principles of the Declaration of Helsinki (revised version of 2013).
Informed Consent: Informed consent was secured from all study participants prior to their inclusion in the study.
Conflict of Interest: LN has served on the advisory boards of Ferring, Abbvie, and Johnson & Johnson, outside the, submitted work. All the other authors declare that they have no conflicts of interest.
